Category Archives: AIA Patent Reform

Takeaways from Chisum Patent Academy’s 2016 Seminars

Posted on August 16, 2016 by Warren Woessner

A guest post from Chisum Patent Academy. On August 4-5 and 8-9, 2016 the Chisum Patent Academy held two advanced patent law roundtable seminars at the historic Mayflower Park Hotel in Seattle, Washington. In addition to covering recent “blockbuster” court decisions, our … Continue reading →

USPTO Publishes Extensive Examination Guidelines for 35 U.S.C. 102 and 103

Posted on February 14, 2013 by Warren Woessner

On February 14, 2013, the PTO published extensive Examination Guidelines for examination of applications filed after March 16, 2013, under 102 and 103 as amended by the AIA. Given the debates, if not confusion, that arose following the publication of … Continue reading →

USPTO Publishes Rule Package on AIA Administrative Trials

Posted on August 14, 2012 by Warren Woessner

While this is primarily a biotechnology patent law blog, the USPTO’s high level of rule making activity deserves attention, as it will affect us all after the September 16th deadline for implementing many of the new features of the AIA … Continue reading →

Posted in AIA Patent Reform | Tagged AIA, biotechnology, Inter Partes Review, Post-Grant Review, Supplemental Examination, Transitional Program [to attack] Business Method Patents, USPTO, Warren Woessner | Leave a comment

Will Universities Benefit from their Micro Entity Applicants?

Posted on June 11, 2012 by Warren Woessner

In an introductory post on the USPTO’s proposed rules: “Changes to Implement Micro Entity Status for Paying Patent Fees,” 77 Fed. Reg. 31806 (May 30 2010), my partner, Gary Speier, spent some time on new 35 USC 123(a), which defines … Continue reading →